vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and Royalty Management Holding Corp (RMCO). Click either name above to swap in a different company.

Royalty Management Holding Corp is the larger business by last-quarter revenue ($1.4M vs $1.1M, roughly 1.2× Insight Molecular Diagnostics Inc.). Royalty Management Holding Corp runs the higher net margin — -29.3% vs -2015.4%, a 1986.0% gap on every dollar of revenue. On growth, Royalty Management Holding Corp posted the faster year-over-year revenue change (469.8% vs -23.4%). Over the past eight quarters, Royalty Management Holding Corp's revenue compounded faster (193.5% CAGR vs 154.4%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Royalties is a brand management agency based in Paris, France. The agency was originally created in 2008 as Publicis Royalties, by Publicis Worldwide and Eurogroup Consulting and is now independently owned by two of the founding partners: David Jobin and Olivier Bontemps. The agency has offices in France and China.

IMDX vs RMCO — Head-to-Head

Bigger by revenue
RMCO
RMCO
1.2× larger
RMCO
$1.4M
$1.1M
IMDX
Growing faster (revenue YoY)
RMCO
RMCO
+493.1% gap
RMCO
469.8%
-23.4%
IMDX
Higher net margin
RMCO
RMCO
1986.0% more per $
RMCO
-29.3%
-2015.4%
IMDX
Faster 2-yr revenue CAGR
RMCO
RMCO
Annualised
RMCO
193.5%
154.4%
IMDX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMDX
IMDX
RMCO
RMCO
Revenue
$1.1M
$1.4M
Net Profit
$-23.0M
$-409.5K
Gross Margin
42.5%
12.9%
Operating Margin
-2057.5%
-2.6%
Net Margin
-2015.4%
-29.3%
Revenue YoY
-23.4%
469.8%
Net Profit YoY
31.5%
-1216.7%
EPS (diluted)
$-0.75
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
RMCO
RMCO
Q4 25
$1.1M
$1.4M
Q3 25
$260.0K
$1.3M
Q2 25
$518.0K
$1.3M
Q1 25
$2.1M
$923.2K
Q4 24
$1.5M
$245.1K
Q3 24
$115.0K
$145.6K
Q2 24
$104.0K
$254.2K
Q1 24
$176.0K
$162.1K
Net Profit
IMDX
IMDX
RMCO
RMCO
Q4 25
$-23.0M
$-409.5K
Q3 25
$-10.9M
$-209.1K
Q2 25
$-9.7M
$-49.5K
Q1 25
$-6.7M
$-58.8K
Q4 24
$-33.5M
$-31.1K
Q3 24
$-13.5M
$-119.2K
Q2 24
$-4.5M
$-117.8K
Q1 24
$-9.1M
$153.8K
Gross Margin
IMDX
IMDX
RMCO
RMCO
Q4 25
42.5%
12.9%
Q3 25
53.5%
11.2%
Q2 25
67.6%
17.0%
Q1 25
62.0%
27.4%
Q4 24
40.0%
99.5%
Q3 24
43.5%
96.3%
Q2 24
48.1%
94.7%
Q1 24
25.6%
98.3%
Operating Margin
IMDX
IMDX
RMCO
RMCO
Q4 25
-2057.5%
-2.6%
Q3 25
-4249.2%
-7.6%
Q2 25
-1900.0%
-3.6%
Q1 25
-318.0%
-12.0%
Q4 24
-2262.9%
-8.9%
Q3 24
-11752.2%
-116.4%
Q2 24
-4453.8%
-53.1%
Q1 24
-5265.3%
8.5%
Net Margin
IMDX
IMDX
RMCO
RMCO
Q4 25
-2015.4%
-29.3%
Q3 25
-4174.6%
-16.0%
Q2 25
-1880.7%
-3.7%
Q1 25
-312.0%
-6.4%
Q4 24
-2255.1%
-12.7%
Q3 24
-11733.0%
-81.8%
Q2 24
-4355.8%
-46.3%
Q1 24
-5186.9%
94.9%
EPS (diluted)
IMDX
IMDX
RMCO
RMCO
Q4 25
$-0.75
$-0.04
Q3 25
$-0.34
$-0.01
Q2 25
$-0.30
$0.00
Q1 25
$-0.26
$0.00
Q4 24
$-2.19
$0.00
Q3 24
$-0.98
$-0.01
Q2 24
$-0.36
$-0.01
Q1 24
$-1.13
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
RMCO
RMCO
Cash + ST InvestmentsLiquidity on hand
$11.6M
$133.1K
Total DebtLower is stronger
Stockholders' EquityBook value
$-31.5M
$13.7M
Total Assets
$25.8M
$16.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
RMCO
RMCO
Q4 25
$11.6M
$133.1K
Q3 25
$18.7M
$173.2K
Q2 25
$24.3M
$146.7K
Q1 25
$31.0M
$132.5K
Q4 24
$8.6M
$114.1K
Q3 24
$3.4M
$145.4K
Q2 24
$9.3M
$39.1K
Q1 24
$5.6M
Total Debt
IMDX
IMDX
RMCO
RMCO
Q4 25
Q3 25
Q2 25
$250.0K
Q1 25
$250.0K
Q4 24
$250.0K
Q3 24
$252.0K
Q2 24
$1.6M
Q1 24
$2.2M
Stockholders' Equity
IMDX
IMDX
RMCO
RMCO
Q4 25
$-31.5M
$13.7M
Q3 25
$-9.2M
$14.1M
Q2 25
$1.1M
$13.9M
Q1 25
$10.2M
$14.0M
Q4 24
$-12.3M
$13.6M
Q3 24
$9.7M
$13.5M
Q2 24
$22.7M
$12.2M
Q1 24
$11.6M
$11.6M
Total Assets
IMDX
IMDX
RMCO
RMCO
Q4 25
$25.8M
$16.7M
Q3 25
$43.9M
$18.0M
Q2 25
$50.5M
$16.9M
Q1 25
$60.4M
$15.7M
Q4 24
$35.1M
$15.0M
Q3 24
$70.2M
$15.4M
Q2 24
$74.7M
$15.2M
Q1 24
$71.0M
$15.1M
Debt / Equity
IMDX
IMDX
RMCO
RMCO
Q4 25
Q3 25
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.13×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
RMCO
RMCO
Operating Cash FlowLast quarter
$-5.5M
$-9.0K
Free Cash FlowOCF − Capex
$-7.0M
FCF MarginFCF / Revenue
-616.7%
Capex IntensityCapex / Revenue
129.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
RMCO
RMCO
Q4 25
$-5.5M
$-9.0K
Q3 25
$-4.5M
$21.9K
Q2 25
$-6.3M
$250.2K
Q1 25
$-5.9M
$-327.1K
Q4 24
$-5.4M
$646.3K
Q3 24
$-5.5M
$439.8K
Q2 24
$-6.0M
$-407.1K
Q1 24
$-3.8M
$-285.3K
Free Cash Flow
IMDX
IMDX
RMCO
RMCO
Q4 25
$-7.0M
Q3 25
$-5.6M
Q2 25
$-6.6M
Q1 25
$-6.2M
Q4 24
$-5.6M
Q3 24
$-5.6M
Q2 24
$-6.2M
Q1 24
$-3.9M
FCF Margin
IMDX
IMDX
RMCO
RMCO
Q4 25
-616.7%
Q3 25
-2135.4%
Q2 25
-1279.5%
Q1 25
-288.4%
Q4 24
-374.5%
Q3 24
-4884.3%
Q2 24
-5931.7%
Q1 24
-2189.8%
Capex Intensity
IMDX
IMDX
RMCO
RMCO
Q4 25
129.9%
Q3 25
403.8%
Q2 25
67.4%
Q1 25
14.4%
Q4 24
14.4%
Q3 24
75.7%
Q2 24
183.7%
Q1 24
13.6%
Cash Conversion
IMDX
IMDX
RMCO
RMCO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-1.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons